Patent Yard Sign in
Canadian application, no grantCanada

Methods and compositions for screening modulators of lipid kinases

CA 2423889 A1 · Owner: Casamitjana, Olivier · Inventors: Melendez, Alirio; Moreau, Francois; Casamitjana, Olivier

CIPO record

Overview

Drawings and full text

Its claims, description and drawings are in the Canadian Patents Database.

Open the CIPO record

Abstract From the Canadian patent

The present invention relates to methods of screening compounds that modulate lipid kinases activity. The invention is more preferably based on the SPA technology to screen compounds that modulate the activity of lipid kinases in , particular membrane lipid kinases more specifically sphingosine kinases. The invention also includes compositions, products kits, etc. for use in , performing the above methods as well as the compounds identified by said methods, and their uses.

Read the whole patent

Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.

Why it's free to use

  • Filed September 28, 2001. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended September 28, 2021.
  • A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by September 28, 2023.
  • We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledSeptember 28, 2001
GrantedNo grant recorded
Term endedSeptember 28, 2021
Patent numberCA 2423889 A1
Classification (IPC)C12Q1/48 +2 more

Timeline

Timeline From CIPO dates

2002200420062008201020122014201620182020Application filedSep 28, 2001Term endedSep 28, 2021

Sources & verification

Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.